Subcutaneous administration of infliximab-attenuated silica-induced lung fibrosis

Abstract

Objectives: To investigate the influence of the anti-tumor necrosis factor-α infliximab (IFX) in the case of rats with silicosis. Material and Methods: Forty-eight Wistar rats were randomly divided into 3 groups. The study group (N = 16) – silicosis was induced by intratracheal instillation of 50 mg silica on day 1, and IFX was subcutaneously administered at a dose of 15 mg/kg of body weight from day 2 to day 6, the vehicle group (N = 16) – silica used as the study group but without IFX, the sham group (N = 16) – 1 ml of saline was intratracheal-used. Eight rats in each group were euthanized on day 7 and on day 14, respectively. Lung tissue sections were stained with hematoxylin and eosin or Masson’s trichromedye. The nuclear factor-κB p65 (NF-κB p65) positioning in the lung tissues were determined by immunohistochemical staining. Levels of tumor necrosis factor α (TNF-α) in rat serum and bronchoalveolar lavage fluid were measured with enzyme linked immunosorbent assay. The inducible nitric oxide synthase (iNOS) mRNA in the lung tissues was measured by quantitative real-time polymerase chain reaction, as well as inhibitor protein-κB (I-κB) and NF-κB p65 expression were measured quantitatively by western blotting. Results: Silica installation increased the lung tissues inflammation reaction, oxidative stress and pulmonary fibrosis. Infliximab treatment significantly improved silica-induced lung pathological changes (inflammatory cells, collagen deposition), decreased the TNF-α inhibited NF-κB signaling (I-κB, NF-κB p65) as well as oxidant status (iNOS). Conclusions: Infliximab may improve silica-induced pulmonary inflammation by decreasing the TNF-α, inhibiting NF-κB signaling (I-κB, NF-κB p65) as well as oxidant status (iNOS), which suggest that IFX has potential role in the treatment of silica-induced lung damage.

Authors and Affiliations

Hua Zhang, Jun-Na Sui, Lei Gao, Jian Guo

Keywords

Related Articles

Letter to the Editor (November 15, 2017) concerning the paper “Screening commercial drivers for obstructive sleep apnea: Validation of STOP-Bang questionnaire”

Refers to: Popević MB, Milovanović A, Nagorni-Obradović L, Nešić D, Milovanović J, Milovanović APS. Screening commercial drivers for obstructive sleep apnea: Validation of STOP-Bang questionnaire. Int J Occup Med Environ...

HAZARDS TO HEARING FROM COMBINED EXPOSURE TO TOLUENE AND NOISE IN RATS

[b]Introduction: [/b]The main risk of hearing impairment from workplace exposure to organic solvents may stem from the potentiation of effects caused by concomitant noise exposure. The aim of the present study was to ide...

AMBIENT AIR POLLUTION AND DAILY EMERGENCY DEPARTMENT VISITS FOR ISCHEMIC STROKE IN EDMONTON, CANADA

[b]Objectives:[/b] In this report, we examine the associations between emergency department (ED) visits for acute ischemic stroke and environmental conditions. [b]Materials and Methods:[/b] The study concerned 10 881 ED...

Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany

Objectives: This study has researched the significance of histologically raised findings and lung dust analyses in the context of claiming the recognition of and thus compensation for an asbestos-associated occupational...

ADVERSE EFFECTS OF EXCESSIVE MOBILE PHONE USE

[b]Introduction:[/b] Research findings indicate that the use of mobile phones may lead to a number of symptoms such as headache, impaired concentration and memory, and also fatigue. [b]Materials and Methods: [/b]The pres...

Download PDF file
  • EP ID EP359570
  • DOI 10.13075/ijomeh.1896.01037
  • Views 103
  • Downloads 0

How To Cite

Hua Zhang, Jun-Na Sui, Lei Gao, Jian Guo (2018). Subcutaneous administration of infliximab-attenuated silica-induced lung fibrosis. International Journal of Occupational Medicine and Environmental Health, 31(4), 503-515. https://www.europub.co.uk/articles/-A-359570